ALKERMES PHARMA IRELAND LIMITED
18 recorded signal(s) across 1 type(s) · recorded between 2012-12-03 and 2026-02-13
Each entry below describes what a public filing records, on the date it was recorded. This page ranks nothing and scores nothing.
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT, recorded 2026-02-13.
confidence 0.95 · as of 2026-02-13 · detail · view patent
unknown · as of 30 Jan 2024 — Release status unknown — no release has been observed for this security interest (releases observed only up to 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT, recorded 2025-10-23.
confidence 0.95 · as of 2025-10-23 · detail · view patent
unknown · as of 30 Jan 2024 — Release status unknown — no release has been observed for this security interest (releases observed only up to 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2024-06-14.
confidence 0.95 · as of 2024-06-14 · detail · view patent
unknown · as of 30 Jan 2024 — Release status unknown — no release has been observed for this security interest (releases observed only up to 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 4 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2023-07-17.
confidence 0.85 · as of 2023-07-17 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 14 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2023-07-17.
confidence 0.85 · as of 2023-07-17 · detail · view patent
released · as of 30 Jan 2024 — Release recorded 21 Nov 2023.
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 9 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2023-07-17.
confidence 0.85 · as of 2023-07-17 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 42 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2020-03-20.
confidence 0.95 · as of 2020-03-20 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 6 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2018-12-04.
confidence 0.95 · as of 2018-12-04 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 4 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2018-12-03.
confidence 0.95 · as of 2018-12-03 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT, recorded 2018-02-07.
confidence 0.95 · as of 2018-02-07 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT, recorded 2018-02-07.
confidence 0.95 · as of 2018-02-07 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 8 patents to MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT, recorded 2017-04-04.
confidence 0.95 · as of 2017-04-04 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 2 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2016-12-19.
confidence 0.95 · as of 2016-12-19 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 3 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2016-05-17.
confidence 0.95 · as of 2016-05-17 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2015-05-19.
confidence 0.95 · as of 2015-05-19 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 3 patents to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2014-06-25.
confidence 0.95 · as of 2014-06-25 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2014-05-28.
confidence 0.95 · as of 2014-05-28 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).
ALKERMES PHARMA IRELAND LIMITED recorded a security interest over 1 patent to MORGAN STANLEY SENIOR FUNDING, INC., recorded 2012-12-03.
confidence 0.85 · as of 2012-12-03 · detail · view patent
active · as of 30 Jan 2024 — No release observed as of 30 Jan 2024 (release coverage ends 30 Jan 2024).